Correction - GSK

By Staff,, Thursday, 22 October 2009 06:00AM

LONDON - Last week's edition of Campaign carried a story that was headlined: "GSK calls £300m media review."

Lucozade…a GSK brand

Lucozade…a GSK brand

We now accept that the story, which suggested that GlaxoSmithKline has called a review of its international media planning and buying arrangements, was incorrect.

GSK has no plans to review either globally or in any of its local markets now or in the near future, but is using Accenture and the US consultancy Medialink to conduct a standard audit of its media buying arrangements.

MediaCom continues to handle the GSK business in the majority of key markets across the world, including the US and UK, while Starcom MediaVest Group continues to handle the business in Central and Eastern Europe.

We apologise for any confusion caused by the story.

This article was first published on


You must log in to use Clip & Save

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Additional Information

Campaign Jobs